Intelligent Bio Solutions (INBS) Asset Writedowns and Impairment (2022 - 2024)
Intelligent Bio Solutions has reported Asset Writedowns and Impairment over the past 3 years, most recently at $263.0 for Q1 2024.
- Quarterly results put Asset Writedowns and Impairment at $263.0 for Q1 2024, down 99.84% from a year ago — trailing twelve months through Mar 2024 was $72115.0 (changed N/A YoY), and the annual figure for FY2023 was $189670.0, changed.
- Asset Writedowns and Impairment for Q1 2024 was $263.0 at Intelligent Bio Solutions, down from $1165.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for INBS hit a ceiling of $163916.0 in Q1 2023 and a floor of $263.0 in Q1 2024.
- Median Asset Writedowns and Impairment over the past 3 years was $12877.0 (2022), compared with a mean of $43158.2.
- Biggest five-year swings in Asset Writedowns and Impairment: plummeted 94.92% in 2023 and later plummeted 99.84% in 2024.
- Intelligent Bio Solutions' Asset Writedowns and Impairment stood at $22918.0 in 2022, then plummeted by 94.92% to $1165.0 in 2023, then plummeted by 77.42% to $263.0 in 2024.
- The last three reported values for Asset Writedowns and Impairment were $263.0 (Q1 2024), $1165.0 (Q4 2023), and $67851.0 (Q3 2023) per Business Quant data.